ReCODE evolved into the broader field of Precision Medicine for cognitive decline. ReCODE helped introduce the idea that Alzheimer’s disease and Mild Cognitive Impairment are often influenced by multiple contributors, such as inflammation, insulin resistance, sleep problems, hormone changes, toxins, infections, nutrient deficiencies, and vascular dysfunction. Precision Medicine expands that model by using individualized evaluation and treatment planning based on each patient’s unique biology. At The Carroll Institute, the Carroll Cognitive Method™ builds on this evolution by integrating Precision Medicine, Functional Medicine, and Functional Neurology.